All About Cataracts

15Jul

Different IOLs yield different rates of posterior capsule opacification

Category: Cataract Surgery

Posterior capsule opacification (PCO) is one of the most common cataract surgery complications. It can occur relatively quickly after cataract surgery or months later.

The natural lens inside the eye is surrounded by a clear, membrane-like capsule. The front portion of this capsule is removed during cataract surgery to gain access to the cloudy natural lens and remove it. The posterior portion of the lens capsule is left intact to prevent loss of the gel-like fluid behind it, which would increase the risk of a detached retina from cataract surgery.

Posterior capsule opacification is thought to be caused by lens epithelial cells remaining in the eye after the cloudy lens is removed during cataract surgery. These cells can migrate onto the surface of the posterior capsule, where they undergo cellular changes and form an opaque membrane that decreases vision.

PCO can be successfully treated with a non-invasive outpatient procedure called a neodymium:YAG (Nd:YAG) laser capsulotomy. The procedure uses laser energy to obliterate the opacity, restoring vision.

Researchers at Storm Eye Institute, Medical University of South Carolina (Charleston, SC) recently conducted a retrospective study of 225 eyes that underwent cataract surgery with intraocular lens (IOL) implantation to investigate whether the type of IOL used in the surgery has an effect on the rate of PCO occurrence.

The eyes in the study received one of three IOLs: AcrySof ReSTOR SN60D3 (a spherical multifocal IOL), AcrySof Natural SN60AT (a spherical monofocal IOL), or AcrySof IQ SN60WF (an aspheric monofocal IOL).

All three IOLs are manufactured and marketed by the same company (Alcon, Inc.). Each lens was implanted in 75 study eyes, and mean follow-up time after surgery was 15.9 months.

The researchers found the rate of posterior capsule opacification after surgery was:

  • 42.7 percent among eyes receiving the spherical multifocal IOL (ReSTOR)
  • 28.0 percent among eyes receiving the spherical monofocal IOL (Natural)
  • 14.7 percent among eyes receiving the aspheric monofocal IOL (IQ)

The Nd:YAG laser capsulotomy rate for eyes receiving the IOLs was 25.3 percent, 17.3 percent and 4.0 percent, respectively.

The researchers concluded that IOL design affects the rate of posterior capsule opacification occurring after cataract surgery.

Also, based on the rates of laser capsulotomy procedures performed, PCO appears to be less visually significant in eyes receiving the AcrySof IQ aspheric monofocal IOL, compared with eyes receiving the spherical multifocal IOL (AcrySof ReSTOR) and the spherical monofocal IOL (AcrySof Natural). 

The study was supported in part by Research to Prevent Blindness and the National Institutes of Health.

Source: Comparison of the incidence and visual significance of posterior capsule opacification between multifocal spherical, monofocal spherical, and monofocal aspheric intraocular lenses. Journal of Cataract & Refractive Surgery. July 2009.


29Jun

Bilateral multifocal IOLs produce better visual outcomes than one-eye implantation

Category: Cataract Surgery

Having multifocal intraocular lenses (IOLs) implanted in both eyes for the treatment of cataracts produces better visual outcomes than a single multifocal IOL implanted in one eye, according to a study published in the June 2009 issue of Journal of Cataract & Refractive Surgery.

In the study, an AcrySof ReSTOR multifocal IOL was implanted 1) in one eye of patients with a natural (non-cataractous) lens in the other eye; 2) in one eye of patients who had a conventional monofocal IOL implanted in the other eye; and 3) in both eyes of patients with a cataract in one or both eyes.

Visual acuity, contrast sensitivity and stereopsis (depth perception) of all eyes was measured six months after cataract surgery. Patients also were surveyed about the quality of their vision and their overall satisfaction.

Patients receiving bilateral multifocal IOLs had the highest satisfaction score (92 percent), and 77 percent of these patients achieved spectacle independence after surgery.

Among patients with the multifocal IOL implanted in one eye only, 75 percent reported being satisfied with their vision, and spectacle independence was achieved by 56 percent of patients with a natural lens in their other eye and 65 percent of those who had a monofocal IOL implanted in their other eye.

Patients with bilateral multifocal IOLs also had better uncorrected near visual acuity, stereopsis, best-corrected near vision and best-corrected intermediate vision.

More patients with bilateral multifocal IOLs (77 percent) experienced halos at night compared with patients who received a multifocal IOL in one eye only (57 percent), but in most cases halos were minot and did not significantly affect patients’ overall satisfaction with their visual outcome.


08Jun

Study compares distance visual acuity of multifocal and monofocal IOLs

Category: Cataract Surgery

Multifocal intraocular lenses (IOLs) provide comparable distance and intermediate visual acuity to that provided by conventional monofocal IOLs and provide the additional benefit of significantly better near vision without reading glasses, according to a new study published in Japanese Journal of Ophthalmology.

The researchers compared visual outcomes for 81 patients who underwent bilateral cataract surgery: 34 patients received non-tinted multifocal IOLs (Alcon ReSTOR), 30 patients received yellow-tinted multifocal IOLs (Alcon ReSTOR Natural) and 17 patients received conventional non-tinted monofocal IOLs.

Results of the study included: 

  • All three types of IOLs provided comparable uncorrected visual acuity for distant and intermediate (arm’s length) viewing.
  • There was no significant difference in the distance visual acuity results for the yellow and non-tinted multifocal IOLs.
  • Both multifocal IOLs provided significantly better uncorrected visual acuity for near viewing, compared to the monofocal IOL.

The study also found that pupil diameter influenced the near visual acuity results of eyes receiving the ReSTOR multifocal IOLs. Patients with larger pupils had better near vision with the multifocal lenses than patients with small pupils.

 

Source:  All-distance visual acuity in eyes with a nontinted or a yellow-tinted diffractive multifocal intraocular lens. Japanese Journal of Ophthalmology. March 2009.


29Dec

Advances in cataract surgery 2008

Category: Cataract Surgery

Advances in cataract surgery are occurring every year, making the procedure safer and more effective than ever.

A number of the key advances in cataract surgery took place in 2008. Among the new technology and techniques:

New Phacoemulsification Technology

Phacoemulsification (or “phaco”) is a cataract surgery technique in which the cataract is broken up into small pieces with a small, hand-held probe that has a vibrating tip. The small pieces are then removed from the eye with suction. Phaco is currently the most common technique used for cataract surgery in the United States.

Manufacturers of phaco equipment for cataract surgery introduced several advances in 2008, including probes that allow the procedure to be performed with smaller incisions. This reduces the risk of unwanted astigmatism after cataract surgery. Other advances include new microsurgical tools to help break up very dense cataracts more effectively during phaco cataract surgery.

New Lens Implants

New intraocular lenses (IOLs) introduced or in development in 2008 include presbyopia-correcting IOLs, aspheric IOLs and toric IOLs.

Presbyopia-correcting IOLs

These innovative lenses help restore a person’s ability to see well up close as well as far away, thereby reducing the need for reading glasses and computer glasses after cataract surgery.

The Crystalens HD (Bausch & Lomb) presbyopia-correcting lens that was introduced in 2008 works by having the ability to change position slightly within the eye in response to focusing effort. This type of presbyopia-correcting IOL is also called an “accommodating” IOL. Other brands of accommodating IOLs are currently in development.

Another type of presbyopia-correcting intraocular lens is the multifocal IOL. Multifocal IOLs are similar in design to multifocal contact lenses, containing separate lens powers for seeing distant, intermediate and near objects simultaneously. Examples of multifocal IOLs include The AcrySof ReSTOR IOL (Alcon Laboratories) and the ReZoom Multifocal Lens (Advanced Medical Optics).

Accommodating and multifocal IOLs can be implanted in both eyes, or in one eye only for a “monovision” effect. Some surgeons feel a monovision correction provides better distance vision than having presbyopia-correcting IOLs implanted in both eyes.

Aspheric IOLs

Aspheric IOLs are specially designed to more closely mimic the shape of the eye’s natural lens, which changes in curvature from its center to its periphery. This characteristic of possessing a gradually changing curve is called asphericity (meaning “not spherical,” or “not of the same curve”).

Because they are more similar in shape to the eye’s natural lens, aspheric IOLs are designed to provide sharper vision and reduce higher-order aberrations (HOAs) caused by traditional spherical IOLs. HOAs contribute to glare and reduced contrast sensitivity, especially at night and in other low-light conditions.

Many cataract surgeons appear to believe in the benefits of aspheric IOLs, as the use of thes premium IOLs grew rapidly in 2008.

Examples of aspheric IOLs include the Tecnis IOL (Advanced Medical Optics) and the AcrySof IQ IOL (Alcon Laboratories).

Toric IOLs

Toric IOLs are a new type of premium intraocular lenses that correct astigmatism.

In the past, people who had astigmatism and cataracts had to wear eyeglasses or have an additional surgical procedure to correct their astigmatism after cataract surgery. With toric IOLs, many of these people can see clearly after cataract surgery without the need for full-time glasses or additional surgery.

Use of toric IOLs increased significantly in 2008 and continued future growth is expected. Examples of toric IOLs include the AcrySof Toric IOL (Alcon Laboratories) and the STAAR Toric IOL (STAAR Surgical Co.)

More Advances on the Horizon

As the aging of the U.S. population continues, more and more Americans are having cataract surgery. And more advances in cataract surgery technology are occurring every year, including techniques for smaller incisions and faster recovery time.

To stay up-to-date on the latest news about cataracts and cataract surgery, return to AllAboutCataracts.com often. Or browse AllAboutVision.com’s Cataract Surgeon Directory to find a cataract surgeon near you.

 

Source: Cataract 2008: A year in review. Ophthalmology Times. December 1, 2008.

 

pages

  • What is a cataract?
  • Cataract surgery
  • Cataract resources

recent articles

  • Alzheimer’s Patients Benefit From Cataract Surgery
  • Long-Term Risk of IOL Dislocation Studied
  • Vegetarian Diet May Lower Cataract Risk

categories

  • Cataract Risk (14)
  • Cataract Surgeon Directory (2)
  • Cataract Surgery (36)
  • Cataract Surgery – New Technology (9)
  • Cataract Surgery Complications (4)
  • Childhood Cataracts (1)
  • Eye Health (9)
  • Intraocular Lenses (IOLs) (20)
  • Research (11)

related topics

  • Asbestos lung disease
  • Asbestos mining
  • Contact Lenses
  • Glaucoma
  • Macular degeneration causes
  • Mesothelioma
  • Pink eye
 


 
© 2000-2012 Access Media Group LLC.